CUSTOMIZE WITH SHOGUN
Skip to Main Content

Board members

Board members

Dynavox Group Board of Directors

Introducing our Board of Directors who offer a wealth of expertise, knowledge and talent to our organization.

Board Member Gitte Pugholm Aabo

Gitte Pugholm Aabo

Chair of the Board

Elected 2024

Born 1967

Education

MBA from Copenhagen Business School, Denmark.

Current assignments and background

Extensive experience from the pharmaceutical industry and in medical technology. Former CEO of the Danish hearing aid company GN Hearing, President and CEO of Danish pharmaceutical company Leo Pharma.

Chair of the GN Foundation and Member of the Boards of ALK-ABELLÓ A/S, Union Therapeutics A/S.

Independent in relation to:

The company and executive management: Yes
Major Shareholders: Yes

Shareholding, own and close related: 0 common shares in the Company.
Board Member Carl Bandhold

Carl Bandhold

Board member

Elected 2021

Born 1974

Education

MBA from INSEAD and MSc in Chemical Engineering from Chalmers University of Technology, Sweden.

Current assignments and background

Formerly deputy CEO and CFO of Profoto AB (publ.), CFO of the assistive technology company Permobil Group, CFO of real estate developer JM AB (publ.) and management consultant at the Boston Consulting Group and Accenture.

Independent in relation to:

The company and executive management: Yes
Major Shareholders: Yes

Shareholding, own and close related: 100,000 common shares in the Company.
Board Member Maarten Barmentlo

Maarten Barmentlo

Board member

Elected 2023

Born 1967

Education

Ph.D. in Physics, University of Leiden, The Netherlands.

Current assignments and background

Extensive experience from senior leadership positions in consumer and professional healthcare businesses globally, e.g. President OTC hearing aid business and CMO at WSA Group, Chief Executive Officer and Board member at Euro-Diesel S.A. General Manager of Philips MRI Systems at Philips Healthcare, CEO Connected Care and CTO Consumer Healthcare Solutions at Philips Consumer Healthcare.

Independent in relation to:

The company and executive management: Yes
Major Shareholders: Yes

Shareholding, own and close related: 0 common shares in the Company.
Board Member Henrik Eskilsson

Henrik Eskilsson

Board member

Elected 2021

Born 1974

Education

MSc in Industrial Engineering & Management, International Profile, Linköping University, Sweden.

Current assignments and background

Co-founder and CEO of Tobii AB from 2001–2021. CEO of Vaja AB.

Board member of Tobii AB.

Independent in relation to:

The company and executive management: No
Major Shareholders: Yes

Shareholding, own and close related: 4,535,952 common shares in the Company.
Board Member Charlotta Falvin

Charlotta Falvin

Board member

Elected 2021

Born 1966

Education

MSc in Business Administration, Lund University, Sweden.

Current assignments and background

Extensive experience from leading positions in IT and telecom, e.g. COO at Axis, CEO at Decuma and TAT. Previously Chair of the Board of Skåne Startups and Board member at companies such as Axis, Boule Diagnostics, Doro, Invisio, Net Insight, Sinch and the Malmö-based incubator Minc.

Chair of the Board of Internetstiftelsen and Science Village Scandinavia AB. Board member of Bure Equity AB, Nel ASA and Tobii AB.

Independent in relation to:

The company and executive management: Yes
Major Shareholders: Yes

Shareholding, own and close related: none common shares in the Company.

Board Member Caroline Ingre

Dr. Caroline Ingre

Board member

Elected 2021

Born 1977

Education

Ph.D. in neuroscience and lecturer at the Karolinska Institutet, Sweden.

Current assignments and background

Specialist and senior physician in neurology and neuromuscular diseases. Founder and director of the Karolinska ALS Center. Founder and director of the national ALS registry in Sweden, as well as the Karolinska ALS Treatment Center, which focuses on clinical trials for ALS. Board member of TRICALS and holds several scientific board positions in ALS-related organizations, including pharmaceutical companies.

Independent in relation to:

The company and executive management: Yes
Major Shareholders: Yes

Shareholding, own and close related: 12,088 common shares in the Company.